Andrew D.C. LaFrence - 23 Nov 2021 Form 4/A - Amendment Insider Report for Vyant Bio, Inc. (VYNT)

Role
Chief Financial Officer
Signature
/s/ Andrew LaFrence
Issuer symbol
VYNT
Transactions as of
23 Nov 2021
Transactions value $
$9,998
Form type
4/A - Amendment
Filing time
29 Dec 2021, 15:30:29 UTC
Date Of Original Report
24 Nov 2021
Previous filing
21 May 2021
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Purchase $10K +5K +17.07% $2.00 34.3K 23 Nov 2021 Direct F1
holding VYNT Common Stock, $0.0001 par value 29.8K 23 Nov 2021 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.9995 to $2.00 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
F2 Includes 3,000 shares previously held directly by the Reporting Person which were transferred to this joint trust account.

Remarks:

This Form 4 is being filed to amend the amount of securities beneficially owned following the reported transaction as reported in the Form 4 filed on November 24, 2021.